Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
CPH Group AG Class A ( (CH:CPHN) ) has provided an announcement.
CPH Group AG has adjusted its earnings forecast for 2025, anticipating an EBITDA of CHF 50 million, lower EBIT, and a reduced net result due to challenges in the global pharmaceutical packaging market, unfavorable exchange rates, and increased costs. Despite these challenges, the company expects revenue to remain above the previous year and continues to focus on cost reductions and process optimizations to improve profitability. The company remains optimistic about its medium-term growth prospects, driven by trends in health, demographics, and energy, and expects stable business development and positive earnings in 2026.
The most recent analyst rating on (CH:CPHN) stock is a Hold with a CHF73.00 price target. To see the full list of analyst forecasts on CPH Group AG Class A stock, see the CH:CPHN Stock Forecast page.
More about CPH Group AG Class A
CPH Group AG operates in the pharmaceutical packaging industry, focusing on products and services related to health and demographics, as well as energy. The company is committed to achieving medium-term growth targets, with an emphasis on sales growth, EBITDA margins, and free cash flow margins.
Average Trading Volume: 688
Technical Sentiment Signal: Buy
Current Market Cap: CHF421.2M
For a thorough assessment of CPHN stock, go to TipRanks’ Stock Analysis page.